Clinically relevant diagnostic research in primary care: The example of B-type natriuretic peptides in the detection of heart failure

Family Practice

Volumn 26, Issue 1, 2009, Pages 69-74

  Kelder, Johannes C ^a,b   Rutten, Frans H ^a   Hoes, Arno W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

B type naturiuretic peptide; Diagnosis; Heart failure; Primary care

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ANAMNESIS; ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; GENERAL PRACTICE; HEART FAILURE; HUMAN; PHYSICAL EXAMINATION; PRIMARY MEDICAL CARE;

ADULT; AGED; AGED, 80 AND OVER; BIOMEDICAL RESEARCH; HEART FAILURE; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PRIMARY HEALTH CARE; YOUNG ADULT;

EID: 59849094293     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmn096     Document Type: Article

References (32)

1. Richardson WS. Five uneasy pieces about pre-test probability. J Gen Intern Med 2002; 17: 882-883.
2. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
3. Rutten FH, Cramer MJ, Zuithoff NP et al. Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail 2007; 9: 651-659.
4. Battaglia M, Pewsner D, Juni P, Egger M, Bucher HC, Bachmann LM. Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: Systematic review of test accuracy studies. Arch Intern Med 2006; 166: 1073-1080.
5. Struthers A, Lang C. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent 'pancardiac' target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur Heart J 2007; 28: 1678-1682.
6. Davenport C, Cheng EY, Kwok YT et al. Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: A systematic review and meta-analysis. Br J Gen Pract 2006; 56: 48-56.
7. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355 1126-1130.
8. Jourdain P, Jondeau G, Funck F et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: The STARS-BNP Multicenter Study. J Am Coll Cardiol 2007; 49: 1733-1739.
9. Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: Cohort study in representative and high risk community populations. Br Med J 2002; 324: 1498.
10. McDonagh TA, Robb SD, Murdoch DR et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
11. Moons KG, van Es GA, Deckers JW, Habbema JD, Grobbee DE. Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: A clinical example. Epidemiology 1997; 8: 12-17.
12. Januzzi JL, van Kimmenade R, Lainchbury J et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: An international pooled analysis of T256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27: 330-337.
13. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
14. De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-322.
15. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008; 29: 2388-2442.
16. Zaphiriou A, Robb S, Murray-Thomas T et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study. Eur J Heart Fail 2005; 7: 537-541.
17. Fuat A, Murphy JJ, Hungin AP et al. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract 2006; 56: 327-333.
18. Nielsen LS, Svanegaard J, Klitgaard A, Egeblad H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail 2004; 6: 63-70.
19. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 2005; 11: S15-S20.
20. Cowie MR, Struthers AD, Wood DA et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1349-1353.
21. Rutten FH, Hoes AW. B-type natriuretic peptide assays for detecting heart failure in the elderly: Same value as those in the younger? Int J Cardiol 2008; 125: 161-165.
22. Moons KG, Grobbee DE. Diagnostic studies as multivariable, prediction research. J Epidemiol Community Health 2002; 56: 337-338.
23. Wells PS, Anderson DR, Bormanis J et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350: 1795-1798.
24. Stiell IG, Greenberg GH, McKnight RD, Nair RC, McDowell I, Worthington JR. A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emerg Med 1992; 21: 384-390.
25. Oudega R, Moons KG, Hoes AW. Ruling out deep venous thrombosis in primary care. A simple diagnostic algorithm including D-dimer testing. Thromb Haemost 2005; 94: 200-205.
26. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med 1980; 302: 1109-1117.
27. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004; 164: 1978-1984.
28. Hill SA, Balion CM, Santaguida P et al. Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care. Clin Biochem 2008; 41: 240-249.
29. Swedberg K, Cleland J, Dargie H et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-1140.
30. Rutten FH, Moons KG, Cramer MJ et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: Cross sectional diagnostic study. Br Med J 2005; 331: 1379.
31. Wright SP, Doughty RN, Pearl A et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: A randomized, controlled trial. J Am Coll Cardiol 2003; 42: 1793-1800.
32. Rutten FH, Grobbee DE, Hoes AW. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: A survey in every-day practice. Eur J Heart Fail 2003; 5: 337-344.